losartan has been researched along with Hemorrhagic Disorders in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Hemorrhagic Disorders: Spontaneous or near spontaneous bleeding caused by a defect in clotting mechanisms (BLOOD COAGULATION DISORDERS) or another abnormality causing a structural flaw in the blood vessels (HEMOSTATIC DISORDERS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with losartan, an angiotensin receptor inhibitor, decreases MYOSIN IIB levels and impedes HPS lung fibroblast migration in vitro." | 1.72 | Dysregulated myosin in Hermansky-Pudlak syndrome lung fibroblasts is associated with increased cell motility. ( Bishop, K; Bodine, SPM; El-Chemaly, S; Gochuico, BR; Handin, R; Imani, J; Lamattina, AM; Ma, DD; Malicdan, MCV; Maynard, DM; Nwokeji, A; Perrella, MA; Rosas, IO; Shrestha, S; Sood, R; Stump, B; Testa, LC; Young, LR, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imani, J | 1 |
| Bodine, SPM | 1 |
| Lamattina, AM | 1 |
| Ma, DD | 1 |
| Shrestha, S | 1 |
| Maynard, DM | 1 |
| Bishop, K | 1 |
| Nwokeji, A | 1 |
| Malicdan, MCV | 1 |
| Testa, LC | 1 |
| Sood, R | 1 |
| Stump, B | 1 |
| Rosas, IO | 1 |
| Perrella, MA | 1 |
| Handin, R | 1 |
| Young, LR | 1 |
| Gochuico, BR | 1 |
| El-Chemaly, S | 1 |
1 other study available for losartan and Hemorrhagic Disorders
| Article | Year |
|---|---|
Dysregulated myosin in Hermansky-Pudlak syndrome lung fibroblasts is associated with increased cell motility.
Topics: Albinism; Animals; Cell Movement; Fibroblasts; Hemorrhagic Disorders; Hermanski-Pudlak Syndrome; Hum | 2022 |